Besides CXCL13 producing CD8+ T cells tumour infiltrating CD4+ T cells also display an enhanced capacity for CXCL13 production in lung cancer, breast cancer and ovarian cancer (6, 14–16). This evidence concerns the gene CD4 and breast cancer.